Will COVID-19 change science? Past pandemics offer clues Penn In the News Science Will COVID-19 change science? Past pandemics offer clues David Barnes of the School of Arts & Sciences spoke about COVID-19 and how pandemics can shape policy. While the 1918 flu was somewhat forgotten, HIV/AIDs has had a lasting impact. The difference, Barnes said, “was activists who were organized and persistent, really beyond anything our society had ever seen.” Vaccine conversations go door-to-door Canvasser Yuhnis Syndor, 57, speaks to Cristal LaTorre, 35, about the vaccine in West Philadelphia, PA, on May 20, 2021. (Image: Penn Medicine Service in Action) Vaccine conversations go door-to-door Canvasser with the West Philadelphia Vaccine Street Team Pilot Program go door to door to dispel misinformation and show their neighbors that vaccination is safe, by example. Pandemic preparedness, three years early Participants in the first PennDemic, which took place in 2018, lay out a timeline of the “outbreak.” Two additional simulations have since taken place, with one more scheduled for this coming fall. Q&A Pandemic preparedness, three years early In a Q&A, team members behind the outbreak simulation PennDemic discuss how the exercise, now in its fourth iteration, equipped an interdisciplinary group of grad students for COVID-19 and beyond. Pfizer suggests booster shots will be needed this year, but government officials say science will dictate the timing Penn In the News The Washington Post Pfizer suggests booster shots will be needed this year, but government officials say science will dictate the timing E. John Wherry of the Perelman School of Medicine spoke about the debate over COVID-19 booster shots. “Current vaccination seems to be largely ‘holding,’” he said. “But the companies seem to suggest that their continued follow up of their trial patients shows concerning levels of waning of immunity. Not much of these data from the companies are publicly available yet. I agree that we need as much independent data and assessment as possible on this topic.” Biden calls for door-to-door vaccine push; experts say more is needed Penn In the News The New York Times Biden calls for door-to-door vaccine push; experts say more is needed PIK Professor Ezekiel Emanuel said workplace mandates may be necessary in order to achieve higher COVID-19 vaccination rates in the U.S. “If the federal government does it, there’s going to be a ton of backlash. It’s going to be a political event,” he said. “If private industry does it, it’s like, ‘OK, that’s private industry, that’s what we’re founded on.’” Vaccine lotteries and beyond: What motivates healthy behaviors Vaccine lotteries and beyond: What motivates healthy behaviors As COVID-19 vaccines have become available to the general public and vaccination rates began to slow, there has been a boom in incentives for receiving the vaccine across the United States. CHIBE’s Kevin Volpp investigates the trend. What to expect as Penn transitions to a fully in-person fall semester As Penn looks forward to a fully in-person campus experience for the fall semester, this summer will be a period of transition as faculty, staff, postdocs, and students navigate evolving public health measures while returning to campus in a way that helps keep the community safe. What to expect as Penn transitions to a fully in-person fall semester Penn Today looks at guidelines for those on campus this summer, what members of the community can expect as they return to campus, and the role that vaccines have in safely resuming in-person activities. Vaccinated and confused? Answers about masks, the Delta variant and breakthrough infections Penn In the News The New York Times Vaccinated and confused? Answers about masks, the Delta variant and breakthrough infections Paul Offit of the Perelman School of Medicine said that the risk of breakthrough infections for people fully vaccinated against COVID-19 goes up in communities where most people aren’t vaccinated. “If you’re in a highly vaccinated community you have sort of a moat around you,” he said. CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result Penn In the News The Washington Post CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result Drew Weissman of the Perelman School of Medicine responded to claims by CureVac executives that their COVID-19 vaccine’s poor results were due to the number of variants, among other factors. “Variants may account for some of their poor efficacy, but the modified [messenger RNA] vaccines have shown good efficacy against variants,” said Weissman. The pandemic, health inequities, and an ‘opportunity for change’ As a global pandemic, COVID-19 spread across the world. But it didn’t hit everyone equally. “Being healthy is essential to human flourishing,” says Jennifer Prah Ruger, who advocates for shared norms in health governance to address global inequalities. (Image: Martin Sanchez, also featured on homepage) The pandemic, health inequities, and an ‘opportunity for change’ Experts across the University weigh in on which lessons the pandemic drove home and what immediate measures are needed to prevent future loss. Load More
Vaccine conversations go door-to-door Canvasser Yuhnis Syndor, 57, speaks to Cristal LaTorre, 35, about the vaccine in West Philadelphia, PA, on May 20, 2021. (Image: Penn Medicine Service in Action) Vaccine conversations go door-to-door Canvasser with the West Philadelphia Vaccine Street Team Pilot Program go door to door to dispel misinformation and show their neighbors that vaccination is safe, by example.
Pandemic preparedness, three years early Participants in the first PennDemic, which took place in 2018, lay out a timeline of the “outbreak.” Two additional simulations have since taken place, with one more scheduled for this coming fall. Q&A Pandemic preparedness, three years early In a Q&A, team members behind the outbreak simulation PennDemic discuss how the exercise, now in its fourth iteration, equipped an interdisciplinary group of grad students for COVID-19 and beyond.
Pfizer suggests booster shots will be needed this year, but government officials say science will dictate the timing Penn In the News The Washington Post Pfizer suggests booster shots will be needed this year, but government officials say science will dictate the timing E. John Wherry of the Perelman School of Medicine spoke about the debate over COVID-19 booster shots. “Current vaccination seems to be largely ‘holding,’” he said. “But the companies seem to suggest that their continued follow up of their trial patients shows concerning levels of waning of immunity. Not much of these data from the companies are publicly available yet. I agree that we need as much independent data and assessment as possible on this topic.” Biden calls for door-to-door vaccine push; experts say more is needed Penn In the News The New York Times Biden calls for door-to-door vaccine push; experts say more is needed PIK Professor Ezekiel Emanuel said workplace mandates may be necessary in order to achieve higher COVID-19 vaccination rates in the U.S. “If the federal government does it, there’s going to be a ton of backlash. It’s going to be a political event,” he said. “If private industry does it, it’s like, ‘OK, that’s private industry, that’s what we’re founded on.’” Vaccine lotteries and beyond: What motivates healthy behaviors Vaccine lotteries and beyond: What motivates healthy behaviors As COVID-19 vaccines have become available to the general public and vaccination rates began to slow, there has been a boom in incentives for receiving the vaccine across the United States. CHIBE’s Kevin Volpp investigates the trend. What to expect as Penn transitions to a fully in-person fall semester As Penn looks forward to a fully in-person campus experience for the fall semester, this summer will be a period of transition as faculty, staff, postdocs, and students navigate evolving public health measures while returning to campus in a way that helps keep the community safe. What to expect as Penn transitions to a fully in-person fall semester Penn Today looks at guidelines for those on campus this summer, what members of the community can expect as they return to campus, and the role that vaccines have in safely resuming in-person activities. Vaccinated and confused? Answers about masks, the Delta variant and breakthrough infections Penn In the News The New York Times Vaccinated and confused? Answers about masks, the Delta variant and breakthrough infections Paul Offit of the Perelman School of Medicine said that the risk of breakthrough infections for people fully vaccinated against COVID-19 goes up in communities where most people aren’t vaccinated. “If you’re in a highly vaccinated community you have sort of a moat around you,” he said. CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result Penn In the News The Washington Post CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result Drew Weissman of the Perelman School of Medicine responded to claims by CureVac executives that their COVID-19 vaccine’s poor results were due to the number of variants, among other factors. “Variants may account for some of their poor efficacy, but the modified [messenger RNA] vaccines have shown good efficacy against variants,” said Weissman. The pandemic, health inequities, and an ‘opportunity for change’ As a global pandemic, COVID-19 spread across the world. But it didn’t hit everyone equally. “Being healthy is essential to human flourishing,” says Jennifer Prah Ruger, who advocates for shared norms in health governance to address global inequalities. (Image: Martin Sanchez, also featured on homepage) The pandemic, health inequities, and an ‘opportunity for change’ Experts across the University weigh in on which lessons the pandemic drove home and what immediate measures are needed to prevent future loss. Load More
Biden calls for door-to-door vaccine push; experts say more is needed Penn In the News The New York Times Biden calls for door-to-door vaccine push; experts say more is needed PIK Professor Ezekiel Emanuel said workplace mandates may be necessary in order to achieve higher COVID-19 vaccination rates in the U.S. “If the federal government does it, there’s going to be a ton of backlash. It’s going to be a political event,” he said. “If private industry does it, it’s like, ‘OK, that’s private industry, that’s what we’re founded on.’” Vaccine lotteries and beyond: What motivates healthy behaviors Vaccine lotteries and beyond: What motivates healthy behaviors As COVID-19 vaccines have become available to the general public and vaccination rates began to slow, there has been a boom in incentives for receiving the vaccine across the United States. CHIBE’s Kevin Volpp investigates the trend. What to expect as Penn transitions to a fully in-person fall semester As Penn looks forward to a fully in-person campus experience for the fall semester, this summer will be a period of transition as faculty, staff, postdocs, and students navigate evolving public health measures while returning to campus in a way that helps keep the community safe. What to expect as Penn transitions to a fully in-person fall semester Penn Today looks at guidelines for those on campus this summer, what members of the community can expect as they return to campus, and the role that vaccines have in safely resuming in-person activities. Vaccinated and confused? Answers about masks, the Delta variant and breakthrough infections Penn In the News The New York Times Vaccinated and confused? Answers about masks, the Delta variant and breakthrough infections Paul Offit of the Perelman School of Medicine said that the risk of breakthrough infections for people fully vaccinated against COVID-19 goes up in communities where most people aren’t vaccinated. “If you’re in a highly vaccinated community you have sort of a moat around you,” he said. CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result Penn In the News The Washington Post CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result Drew Weissman of the Perelman School of Medicine responded to claims by CureVac executives that their COVID-19 vaccine’s poor results were due to the number of variants, among other factors. “Variants may account for some of their poor efficacy, but the modified [messenger RNA] vaccines have shown good efficacy against variants,” said Weissman. The pandemic, health inequities, and an ‘opportunity for change’ As a global pandemic, COVID-19 spread across the world. But it didn’t hit everyone equally. “Being healthy is essential to human flourishing,” says Jennifer Prah Ruger, who advocates for shared norms in health governance to address global inequalities. (Image: Martin Sanchez, also featured on homepage) The pandemic, health inequities, and an ‘opportunity for change’ Experts across the University weigh in on which lessons the pandemic drove home and what immediate measures are needed to prevent future loss. Load More
Vaccine lotteries and beyond: What motivates healthy behaviors Vaccine lotteries and beyond: What motivates healthy behaviors As COVID-19 vaccines have become available to the general public and vaccination rates began to slow, there has been a boom in incentives for receiving the vaccine across the United States. CHIBE’s Kevin Volpp investigates the trend.
What to expect as Penn transitions to a fully in-person fall semester As Penn looks forward to a fully in-person campus experience for the fall semester, this summer will be a period of transition as faculty, staff, postdocs, and students navigate evolving public health measures while returning to campus in a way that helps keep the community safe. What to expect as Penn transitions to a fully in-person fall semester Penn Today looks at guidelines for those on campus this summer, what members of the community can expect as they return to campus, and the role that vaccines have in safely resuming in-person activities.
Vaccinated and confused? Answers about masks, the Delta variant and breakthrough infections Penn In the News The New York Times Vaccinated and confused? Answers about masks, the Delta variant and breakthrough infections Paul Offit of the Perelman School of Medicine said that the risk of breakthrough infections for people fully vaccinated against COVID-19 goes up in communities where most people aren’t vaccinated. “If you’re in a highly vaccinated community you have sort of a moat around you,” he said. CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result Penn In the News The Washington Post CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result Drew Weissman of the Perelman School of Medicine responded to claims by CureVac executives that their COVID-19 vaccine’s poor results were due to the number of variants, among other factors. “Variants may account for some of their poor efficacy, but the modified [messenger RNA] vaccines have shown good efficacy against variants,” said Weissman. The pandemic, health inequities, and an ‘opportunity for change’ As a global pandemic, COVID-19 spread across the world. But it didn’t hit everyone equally. “Being healthy is essential to human flourishing,” says Jennifer Prah Ruger, who advocates for shared norms in health governance to address global inequalities. (Image: Martin Sanchez, also featured on homepage) The pandemic, health inequities, and an ‘opportunity for change’ Experts across the University weigh in on which lessons the pandemic drove home and what immediate measures are needed to prevent future loss. Load More
CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result Penn In the News The Washington Post CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result Drew Weissman of the Perelman School of Medicine responded to claims by CureVac executives that their COVID-19 vaccine’s poor results were due to the number of variants, among other factors. “Variants may account for some of their poor efficacy, but the modified [messenger RNA] vaccines have shown good efficacy against variants,” said Weissman. The pandemic, health inequities, and an ‘opportunity for change’ As a global pandemic, COVID-19 spread across the world. But it didn’t hit everyone equally. “Being healthy is essential to human flourishing,” says Jennifer Prah Ruger, who advocates for shared norms in health governance to address global inequalities. (Image: Martin Sanchez, also featured on homepage) The pandemic, health inequities, and an ‘opportunity for change’ Experts across the University weigh in on which lessons the pandemic drove home and what immediate measures are needed to prevent future loss.
The pandemic, health inequities, and an ‘opportunity for change’ As a global pandemic, COVID-19 spread across the world. But it didn’t hit everyone equally. “Being healthy is essential to human flourishing,” says Jennifer Prah Ruger, who advocates for shared norms in health governance to address global inequalities. (Image: Martin Sanchez, also featured on homepage) The pandemic, health inequities, and an ‘opportunity for change’ Experts across the University weigh in on which lessons the pandemic drove home and what immediate measures are needed to prevent future loss.